Rudy Thoms

Rudy Thoms is an accomplished professional in the medical device and diabetes care sectors, currently serving as Vice President and General Manager of Commercial Continuous Glucose Monitoring at Ascensia Diabetes Care since January 2022. Prior experience includes a role in Neurovascular sales at Stryker, focusing on the competitive Neurosurgery market, and a significant tenure as Head of U.S. Sales at Senseonics, where Rudy was integral to the start-up and global commercialization of innovative Continuous Glucose Monitoring therapies. With a history at Medtronic spanning over a decade, Rudy held various leadership positions, managing substantial revenue streams and earning multiple awards for outstanding sales performance. Earlier career accomplishments at Aventis established a strong foundation in specialty sales and clinical presentations. Rudy holds a Bachelor of Arts degree in Business Communications and Theatre from the University of North Carolina Wilmington.